Evidence map›Paper›PMID 31933263›Full record

ArticleMolecular biology reports2020

A novel bioactive nanoparticle synthesized by conjugation of 3-chloropropyl trimethoxy silane functionalized Fe

Seyyedeh Zahra Habibzadeh, Ali Salehzadeh, Zeinab Moradi-Shoeili, Seyed Ataollah Sadat Shandiz

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Determination of anticancer potential of a novel pharmacologically active thiosemicarbazone derivative against colorectal cancer cell lines.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seyyedeh Zahra HabibzadehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Ali SalehzadehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran. salehzadeh@iaurasht.ac.ir.ORCID http://orcid.org/0000-0003-4238-0999
Zeinab Moradi-ShoeiliDepartment of Chemistry, Faculty of Sciences, University of Guilan, P.O. Box 41335-1914, Rasht, Iran.
Seyed Ataollah Sadat ShandizDepartment of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is one of the common types of cancer around the world which has few therapeutic options. Nitrogen heterocyclic derivatives such as thiazoles are used as the basis for the progression of the drugs. The objective of this study was to synthesize the 1-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl) methylene)-2-(4-phenylthiazol-2-yl) hydrazine (TP) conjugating with (3-Chloropropyl) trimethoxysilane (CPTMOS)-coated Fe

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorCell SurvivalDose-Response Relationship, DrugFerric CompoundsHumansHydrazinesMicroscopy, ElectronModels, ChemicalMolecular StructureNanoparticlesNecrosisReactive Oxygen SpeciesSilanesSpectroscopy, Fourier Transform Infrared3-chloropropyltrimethoxysilaneAntineoplastic AgentsFerric CompoundsHydrazinesReactive Oxygen SpeciesSilanes(3-Chloropropyl) trimethoxysilaneFlow cytometryGastric cancerIron oxide nanoparticleMTTThiazole

Identifiers

PMID31933263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.